查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2141719

寵物疾病診斷劑市場：全球市場預測，2026-2032年

Pet Disease Diagnostic Reagent Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，寵物疾病診斷劑市場規模將達到 14.1072 億美元，複合年成長率為 6.83%。

主要市場統計數據
基準年 2025 8.8778億美元
預計年份：2026年 9.4197億美元
預測年份 2032 1,410,720,000 美元
複合年成長率 (%) 6.83%

寵物疾病診斷劑：概述

寵物疾病診斷劑可用於檢測和監測伴侶動物的感染疾病、寄生蟲疾病、遺傳性疾病、發炎性疾病和代謝性疾病。其應用範圍涵蓋獸醫院、診斷檢查室、動物保險機構、動物收容所、研究機構和即時檢測點。市場需求主要受以下因素驅動：伴侶動物數量的成長、人們對預防醫學日益成長的興趣、獸醫服務可及性的提高以及對更快臨床決策的需求。產品性能取決於分析靈敏度、特異性、與檢體的兼容性、操作便捷性、儲存要求以及在相關物種和疾病標靶中的檢驗結果。

更快捷、更便捷的檢測方法正在改變獸醫診斷的方式。

該領域正從以檢查室為中心的檢測模式轉向將集中式診斷與患者現場檢測流程相結合的模式。快速免疫檢測、分子診斷、多重檢測和數位連接的儀器正在幫助臨床醫生縮短診斷流程，同時確保必要的確認性檢測。在獸醫實踐中，易用性、清晰的結果解讀、品管以及與電子健康記錄的整合變得越來越重要。監管要求、生物安全考量、合理使用抗生素以及區分具有臨床意義的感染疾病和偶然發現的需求，正日益影響產品的選擇和實施。

人工智慧（AI）正在改善決策、工作流程和監控。

人工智慧 (AI) 透過輔助影像解讀、模式識別、結果篩選、品質保證以及整合實驗室觀察和臨床病史，為寵物疾病診斷做出貢獻。機器學習系統可以幫助識別異常訊號並優先處理需要重新評估的病例，但其效用取決於代表性的訓練資料、物種特異性檢驗、透明的性能指標以及防止自動化偏差的安全措施。人工智慧還可以透過識別匿名實驗室結果中的趨勢來支援流行病學監測。人工監督仍然至關重要，尤其是在假陰性、假陽性或非典型症狀可能對治療決策產生重大影響的情況下。

區域趨勢反映了獸醫護理和診斷基礎設施方面的不平衡。

在北美，伴侶動物醫療保健服務普及率高，診所內檢測、參考實驗室和數位化獸醫工作流程也廣泛應用。拉丁美洲的都市區寵物飼養量增加，以及預防性醫療保健的普及，為該地區帶來了機遇，但價格、分銷和實驗室可用性仍然是重要的限制因素。歐洲受惠於完善的獸醫系統和監管協調，其需求主要來自動物福利、合理使用抗菌藥物和跨境疾病監測。在中東，部分都市區對伴侶動物服務的投資正在增加，但市場准入和進口要求因地區而異。在非洲，基礎設施不平衡、感染疾病負擔和人力資源可用性造成了多樣化的需求。亞太地區擁有高度發展的獸醫市場和快速發展的醫療保健體系，因此對先進的檢測平台和經濟高效的照護現場試劑都有需求。

經濟和政策群體為實施創造了不同的條件。

東協市場的特點是獸醫基礎設施不均衡、都市區寵物數量不斷增加以及監管管道各異，因此本地分銷和實踐培訓至關重要。金磚國家擁有龐大且多樣化的動物健康需求，但在檢測能力、報銷機制和採購系統方面存在顯著差異。歐盟受益於協調一致的監管原則和跨境監管，但各國的具體實施方案和採購慣例仍存在差異。七國集團（G7）國家普遍支持先進的獸醫服務、品管系統和數位化整合，但也實施了嚴格的合規要求。海灣合作理事會（GCC）市場的需求集中在設備完善的都市區和私人診所，同時也表現出對進口技術的依賴。北約成員國的獸醫體系各不相同，但韌性、生物安全和供應連續性是通用的策略考量。

每個國家的優先事項各不相同，從深入一體化到擴大進入範圍。

澳洲強調生物安全、專業獸醫護理以及在人口分散地區提供地理位置適宜的醫療服務。巴西擁有大規模的伴侶動物，但臨床能力和分佈存在區域差異。加拿大的診斷系統體現了先進的獸醫服務以及服務偏遠社區所面臨的實際挑戰。中國在應對不斷變化的監管要求的同時，也在不斷擴展獸醫基礎設施並推廣數位醫療。法國、德國、義大利和西班牙受益於成熟的伴侶動物照護網路，其需求受品質保證、檢查室標準和預防醫學的影響。印度透過擴大寵物護理和獸醫服務的覆蓋範圍，擁有巨大的長期發展潛力，但其經濟能力和基礎設施存在差異。日本和韓國強調以技術為支撐的高品質臨床服務。墨西哥正在建立伴侶動物醫療保健生態系統，但醫療服務取得仍然存在差異。俄羅斯的診斷用品供應受到國內生產、進口條件和區域差異的影響。英國保持著高水準的獸醫護理和檢測能力，同時注重監管和合理使用抗生素。美國結合了廣泛的臨床能力、參考測試和即時檢測的實施，採購決策越來越受到工作流程效率和效能展示的影響。

優先考慮驗證、工作流程相容性和穩健的分發。

產業領導者應優先選擇已在相關物種、檢體類型、疾病階段和臨床環境中經過透明檢驗的試劑。產品系列應兼顧快速即時檢測配方和基於檢查室的確診方法，並在結果不一致或不確定時提供明確的指南。與獸醫網路、實驗室、大學和公共衛生相關人員夥伴關係，可以提升真實世界證據和監測的價值。商業性推廣應考慮當地監管要求、冷鏈限制、技術人員培訓、設備維護和價格合理性。領導者還應建立健全的品管體系，在實際可行的範圍內確保關鍵材料的兩份來源，以保護診斷數據，並且僅在檢驗、監測和臨床醫生監督均有記錄的情況下才使用人工智慧。

數據驅動的市場估值調查方法

本執行摘要系統性地回顧了寵物疾病診斷劑如何影響其應用。報告以定性方式呈現了區域、群體和國家層面的具體觀察結果，避免了未經證實的市場估算、預測或公司聲明。解讀時應參考最新的監管文件、同行評審的檢驗研究、獸醫使用數據、採購記錄以及與合格的臨床和實驗室專業人員的訪談。

可靠的試劑能夠實現更快、更負責任的寵物照護。

寵物疾病診斷試劑在預防醫學、高效臨床決策和動物疾病監測中發揮日益重要的作用。最大的商業機會在於可靠的性能、便捷的工作流程、可互通的數據以及適用於不同獸醫環境的解決方案。未來的發展取決於創新與嚴格檢驗的結合、負責任的人工智慧管治、穩健的供應鏈以及對臨床醫生的培訓。那些能夠平衡技術品質、實用性和本地需求的機構，將更有能力幫助提高伴侶動物的診斷準確性和治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：寵物疾病診斷劑市場：依疾病類別分類

  • 遺傳性疾病
  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 病毒感染疾病
  • 代謝性疾病
  • 腫瘤學
  • 寄生蟲病
    • 體外寄生蟲感染疾病
    • 蠕蟲感染疾病
    • 原蟲性疾病

第8章：寵物疾病診斷劑市場：依動物類型分類

  • 貓
  • 狗
  • 馬
  • 家畜
  • 家禽

第9章：寵物疾病診斷劑市場：依診斷技術分類

  • 酵素免疫分析法（ELISA）
  • 免疫組織化學
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 快速檢測

第10章：寵物疾病診斷劑市場：依檢測類型分類

  • 抗體檢測
  • 抗原檢測
  • 生物化學檢驗
  • 分子檢測
    • 等溫擴增試驗
    • NGS檢測
    • PCR檢測
    • qPCR檢測

第11章：寵物疾病診斷劑市場：以最終用戶分類

  • 家庭測試
  • 研究機構
  • 獸醫診斷檢查室
  • 動物醫院

第12章：寵物疾病診斷劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：寵物疾病診斷劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：寵物疾病診斷劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agrolabo SpA
  • Alvedia SAS
  • Antech Diagnostics Inc.
  • Bio-Rad Laboratories Inc.
  • BioChek BV
  • Biogal Galed Laboratories Ltd.
  • bioMerieux SA
  • BioNote Inc.
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Heska Corporation
  • IDEXX Laboratories Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • Mars Incorporated
  • MEGACOR Diagnostik GmbH
  • Merck & Co. Inc.
  • NEOGEN Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Animal Medical Technology Co. Ltd.
  • Synlab Vet GmbH
  • Thermo Fisher Scientific Inc.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

第17章 主要專家

Product Code: MRR-9C4233EE5E49

The Pet Disease Diagnostic Reagent Market is projected to grow by USD 1,410.72 million at a CAGR of 6.83% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 887.78 million
Estimated Year [2026] USD 941.97 million
Forecast Year [2032] USD 1,410.72 million
CAGR (%) 6.83%

Pet Disease Diagnostic Reagents: Executive Overview

Pet disease diagnostic reagents support the detection and monitoring of infectious, parasitic, genetic, inflammatory, and metabolic conditions in companion animals. Their use spans veterinary clinics, diagnostic laboratories, animal hospitals, shelters, research settings, and point-of-care environments. Demand is shaped by rising companion-animal ownership, greater attention to preventive care, improved veterinary access, and the need for faster clinical decisions. Product performance depends on analytical sensitivity, specificity, sample compatibility, workflow simplicity, storage requirements, and validation across relevant species and disease targets.

Faster, More Accessible Testing Is Reshaping Veterinary Diagnostics

The field is moving from exclusively laboratory-centered testing toward a combination of centralized diagnostics and near-patient workflows. Rapid immunoassays, molecular methods, multiplex panels, and digitally connected instruments are helping clinicians shorten diagnostic pathways while maintaining appropriate confirmatory testing. Veterinary practices are also placing greater emphasis on ease of use, clear interpretation, quality control, and integration with electronic medical records. Regulatory expectations, biosafety considerations, antimicrobial stewardship, and the need to distinguish clinically meaningful infection from incidental detection are increasingly influencing product selection and implementation.

Artificial Intelligence Is Improving Interpretation, Workflow, and Surveillance

Artificial intelligence is contributing to pet disease diagnostics by assisting with image interpretation, pattern recognition, result triage, quality assurance, and integration of laboratory findings with clinical histories. Machine-learning systems can help identify abnormal signals or prioritize cases for review, but their usefulness depends on representative training data, species-specific validation, transparent performance metrics, and safeguards against automation bias. AI can also support epidemiological surveillance by identifying trends across anonymized test results. Human oversight remains essential, particularly where false negatives, false positives, or atypical presentations could materially affect treatment decisions.

Regional Dynamics Reflect Uneven Veterinary Access and Diagnostic Infrastructure

North America combines broad companion-animal healthcare access with strong adoption of in-clinic testing, reference laboratories, and digital veterinary workflows. Latin America presents opportunities linked to expanding urban pet ownership and preventive care, while affordability, distribution, and laboratory availability remain important constraints. Europe benefits from established veterinary systems and regulatory coordination, with demand influenced by animal welfare, antimicrobial stewardship, and cross-border disease surveillance. The Middle East is seeing greater investment in companion-animal services in selected urban centers, although market access and import requirements vary. Africa has diverse needs shaped by uneven infrastructure, infectious-disease burdens, and workforce availability. Asia-Pacific spans highly developed veterinary markets and rapidly expanding care systems, creating demand for both sophisticated laboratory platforms and cost-effective point-of-care reagents.

Economic and Policy Groups Create Distinct Adoption Conditions

ASEAN markets are characterized by varied veterinary infrastructure, growing urban pet populations, and differing regulatory pathways, making local distribution and practical training important. BRICS countries combine large and diverse animal-health needs with substantial differences in laboratory capacity, reimbursement, and procurement systems. The European Union benefits from coordinated regulatory principles and cross-border surveillance, while national implementation and purchasing practices still differ. G7 countries generally support advanced veterinary services, quality systems, and digital integration, but also apply rigorous compliance expectations. GCC markets show concentrated demand in well-equipped urban and private-care settings, alongside reliance on imported technologies. NATO members encompass diverse veterinary systems, yet resilience, biosafety, and supply continuity are common strategic considerations.

Country Priorities Range from Advanced Integration to Access Expansion

Australia emphasizes biosecurity, specialized veterinary care, and geographically appropriate access across dispersed populations. Brazil combines a large companion-animal base with regional differences in clinical capacity and distribution. Canada's diagnostic environment reflects advanced veterinary services alongside the practical challenges of serving remote communities. China is expanding veterinary infrastructure and digital health adoption while navigating evolving regulatory requirements. France, Germany, Italy, and Spain benefit from established companion-animal care networks, with demand shaped by quality assurance, laboratory standards, and preventive medicine. India presents strong long-term potential through expanding pet care and veterinary access, although affordability and infrastructure vary. Japan and South Korea emphasize technology-enabled, high-quality clinical services. Mexico is developing its companion-animal healthcare ecosystem amid uneven access. Russia's diagnostic supply environment is influenced by domestic production, import conditions, and regional disparities. The United Kingdom maintains sophisticated veterinary and laboratory capabilities, with attention to regulation and responsible antimicrobial use. The United States combines extensive clinical capacity, reference testing, and point-of-care adoption, with purchasing decisions increasingly tied to workflow efficiency and evidence of performance.

Prioritize Validation, Workflow Fit, and Resilient Distribution

Industry leaders should prioritize reagents with transparent validation across relevant species, sample types, disease stages, and clinical settings. Product portfolios should balance rapid point-of-care formats with laboratory-confirmatory methods and provide clear guidance for discordant or inconclusive results. Partnerships with veterinary networks, laboratories, universities, and public-health stakeholders can strengthen real-world evidence and surveillance value. Commercial execution should account for regional regulatory requirements, cold-chain limitations, technician training, instrument maintenance, and affordability. Leaders should also establish robust quality systems, dual-source critical inputs where practical, protect diagnostic data, and use AI only with documented validation, monitoring, and clinician oversight.

Methodology for a Data-Grounded Market Assessment

This executive summary uses a structured review of the pet disease diagnostic reagent landscape, organized around product application, veterinary workflow, technology, regulation, infrastructure, and geography. The assessment distinguishes established diagnostic practices from emerging capabilities and considers how clinical demand, laboratory access, procurement, quality requirements, and disease-surveillance needs influence adoption. Regional, group, and country observations are presented qualitatively and avoid unsupported market estimates, shares, forecasts, or company-specific claims. Interpretation should be supplemented with current regulatory documents, peer-reviewed validation studies, veterinary utilization data, procurement records, and interviews with qualified clinical and laboratory professionals.

Reliable Reagents Will Enable More Timely, Responsible Pet Care

Pet disease diagnostic reagents are becoming more central to preventive medicine, efficient clinical decision-making, and surveillance of animal disease. The strongest opportunities are associated with dependable performance, accessible workflows, interoperable data, and solutions suited to differing veterinary environments. Progress will depend on combining innovation with rigorous validation, responsible AI governance, resilient supply chains, and clinician education. Organizations that align technical quality with practical usability and regional needs will be better positioned to support accurate diagnosis and improved outcomes for companion animals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pet Disease Diagnostic Reagent Market, by Disease Category

  • 7.1. Introduction
  • 7.2. Genetic Disorder
  • 7.3. Infectious Disease
    • 7.3.1. Bacterial Infection
    • 7.3.2. Fungal Infection
    • 7.3.3. Viral Infection
  • 7.4. Metabolic Disorder
  • 7.5. Oncology
  • 7.6. Parasitic Disease
    • 7.6.1. Ectoparasitic Infection
    • 7.6.2. Helminth Infection
    • 7.6.3. Protozoan Infection

8. Pet Disease Diagnostic Reagent Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Cat
  • 8.3. Dog
  • 8.4. Equine
  • 8.5. Livestock
  • 8.6. Poultry

9. Pet Disease Diagnostic Reagent Market, by Diagnostic Technology

  • 9.1. Introduction
  • 9.2. Enzyme Linked Immunosorbent Assay
  • 9.3. Immunohistochemistry
  • 9.4. Next Generation Sequencing
  • 9.5. Polymerase Chain Reaction
  • 9.6. Rapid Test

10. Pet Disease Diagnostic Reagent Market, by Test Type

  • 10.1. Introduction
  • 10.2. Antibody Test
  • 10.3. Antigen Test
  • 10.4. Biochemical Test
  • 10.5. Molecular Test
    • 10.5.1. Isothermal Amplification Test
    • 10.5.2. NGS Test
    • 10.5.3. PCR Test
    • 10.5.4. qPCR Test

11. Pet Disease Diagnostic Reagent Market, by End User

  • 11.1. Introduction
  • 11.2. Homecare Testing
  • 11.3. Research Institute
  • 11.4. Veterinary Diagnostic Lab
  • 11.5. Veterinary Hospital

12. Pet Disease Diagnostic Reagent Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Pet Disease Diagnostic Reagent Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Pet Disease Diagnostic Reagent Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agrolabo S.p.A.
  • 16.2. Alvedia SAS
  • 16.3. Antech Diagnostics Inc.
  • 16.4. Bio-Rad Laboratories Inc.
  • 16.5. BioChek B.V.
  • 16.6. Biogal Galed Laboratories Ltd.
  • 16.7. bioMerieux S.A.
  • 16.8. BioNote Inc.
  • 16.9. Fassisi GmbH
  • 16.10. FUJIFILM Holdings Corporation
  • 16.11. Heska Corporation
  • 16.12. IDEXX Laboratories Inc.
  • 16.13. INDICAL BIOSCIENCE GmbH
  • 16.14. Innovative Diagnostics SAS
  • 16.15. Mars Incorporated
  • 16.16. MEGACOR Diagnostik GmbH
  • 16.17. Merck & Co. Inc.
  • 16.18. NEOGEN Corporation
  • 16.19. Randox Laboratories Ltd.
  • 16.20. Shenzhen Mindray Animal Medical Technology Co. Ltd.
  • 16.21. Synlab Vet GmbH
  • 16.22. Thermo Fisher Scientific Inc.
  • 16.23. Vetoquinol S.A.
  • 16.24. Virbac S.A.
  • 16.25. Zoetis Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Pet Disease Diagnostic Reagent Market, Years Considered for the Study
  • FIGURE 2. Global Pet Disease Diagnostic Reagent Market, Research Design
  • FIGURE 3. Global Pet Disease Diagnostic Reagent Market, Research Framework
  • FIGURE 4. Global Pet Disease Diagnostic Reagent Market, Data Triangulation
  • FIGURE 5. Global Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2025 vs 2032 (%)
  • FIGURE 7. Global Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2025 vs 2032 (%)
  • FIGURE 11. Global Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Pet Disease Diagnostic Reagent Market Size, by Test Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Pet Disease Diagnostic Reagent Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Pet Disease Diagnostic Reagent Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Pet Disease Diagnostic Reagent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Pet Disease Diagnostic Reagent Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Pet Disease Diagnostic Reagent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Pet Disease Diagnostic Reagent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Pet Disease Diagnostic Reagent Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Pet Disease Diagnostic Reagent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Pet Disease Diagnostic Reagent Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Pet Disease Diagnostic Reagent Market Segmentation & Coverage
  • TABLE 2. Global Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 4. Global Genetic Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Genetic Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Genetic Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Fungal Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Fungal Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Fungal Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Metabolic Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Metabolic Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Metabolic Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Parasitic Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Parasitic Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Parasitic Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Ectoparasitic Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Ectoparasitic Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Ectoparasitic Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Helminth Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Helminth Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Helminth Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Protozoan Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Protozoan Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Protozoan Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 38. Global Cat Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Cat Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Cat Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Dog Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Dog Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Dog Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 54. Global Enzyme Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Enzyme Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Enzyme Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Immunohistochemistry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Immunohistochemistry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Immunohistochemistry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Rapid Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Rapid Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Rapid Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 70. Global Antibody Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Antibody Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Antibody Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Antigen Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Antigen Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Antigen Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Biochemical Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Biochemical Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Biochemical Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Molecular Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Molecular Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Molecular Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Isothermal Amplification Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Isothermal Amplification Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Isothermal Amplification Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global NGS Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global NGS Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global NGS Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global PCR Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global PCR Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global PCR Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global qPCR Test Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global qPCR Test Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global qPCR Test Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 95. Global Homecare Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Homecare Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Homecare Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Research Institute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Research Institute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Research Institute Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Veterinary Diagnostic Lab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Veterinary Diagnostic Lab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Veterinary Diagnostic Lab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Veterinary Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Veterinary Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Veterinary Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. North America Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. North America Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 119. North America Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 120. North America Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 121. North America Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 122. North America Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 123. North America Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 124. North America Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 125. North America Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 126. Latin America Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 127. Latin America Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 128. Latin America Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 129. Latin America Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 130. Latin America Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 131. Latin America Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 132. Latin America Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 133. Latin America Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 134. Latin America Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 135. Europe Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 136. Europe Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 137. Europe Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 138. Europe Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 139. Europe Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 140. Europe Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 141. Europe Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 142. Europe Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 143. Europe Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. Middle East Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Middle East Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 146. Middle East Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 147. Middle East Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 148. Middle East Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 149. Middle East Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 150. Middle East Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 151. Middle East Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 152. Middle East Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 153. Africa Pet Disease Diagnostic Reagent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 154. Africa Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 155. Africa Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 156. Africa Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 157. Africa Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 158. Africa Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 159. Africa Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 160. Africa Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 161. Africa Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 162. Global Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 163. ASEAN Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. ASEAN Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 165. ASEAN Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 166. ASEAN Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 167. ASEAN Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 168. ASEAN Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 169. ASEAN Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 170. ASEAN Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 171. ASEAN Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. GCC Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. GCC Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 174. GCC Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 175. GCC Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 176. GCC Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 177. GCC Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 178. GCC Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 179. GCC Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 180. GCC Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. European Union Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 182. European Union Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 183. European Union Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 184. European Union Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 185. European Union Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 186. European Union Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 187. European Union Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 188. European Union Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 189. European Union Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. BRICS Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 191. BRICS Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 192. BRICS Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 193. BRICS Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 194. BRICS Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 195. BRICS Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 196. BRICS Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 197. BRICS Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 198. BRICS Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 199. G7 Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 200. G7 Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 201. G7 Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 202. G7 Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 203. G7 Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 204. G7 Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 205. G7 Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 206. G7 Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 207. G7 Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 208. NATO Pet Disease Diagnostic Reagent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 209. NATO Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 210. NATO Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 211. NATO Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 212. NATO Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 213. NATO Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 214. NATO Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 215. NATO Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 216. NATO Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. Global Pet Disease Diagnostic Reagent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 218. United States Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 219. United States Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 220. United States Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 221. United States Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 222. United States Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 223. United States Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 224. United States Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 225. United States Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 226. United States Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 227. Canada Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 228. Canada Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 229. Canada Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 230. Canada Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 231. Canada Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 232. Canada Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 233. Canada Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 234. Canada Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 235. Canada Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 236. Mexico Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 237. Mexico Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 238. Mexico Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 239. Mexico Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 240. Mexico Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 241. Mexico Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 242. Mexico Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 243. Mexico Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 244. Mexico Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. Brazil Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 246. Brazil Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 247. Brazil Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 248. Brazil Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 249. Brazil Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 250. Brazil Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 251. Brazil Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 252. Brazil Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 253. Brazil Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. United Kingdom Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 255. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 256. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 257. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 260. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 261. United Kingdom Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 262. United Kingdom Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 263. Germany Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 264. Germany Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 265. Germany Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 266. Germany Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 267. Germany Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 268. Germany Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 269. Germany Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 270. Germany Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 271. Germany Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. France Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 273. France Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 274. France Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 275. France Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 276. France Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 277. France Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 278. France Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 279. France Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 280. France Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 281. Russia Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 282. Russia Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 283. Russia Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 284. Russia Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 285. Russia Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 286. Russia Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 287. Russia Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 288. Russia Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 289. Russia Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. Italy Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 291. Italy Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 292. Italy Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 293. Italy Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 294. Italy Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 295. Italy Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 296. Italy Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 297. Italy Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 298. Italy Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 299. Spain Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 300. Spain Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 301. Spain Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 302. Spain Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 303. Spain Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 304. Spain Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 305. Spain Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 306. Spain Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 307. Spain Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 308. China Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 309. China Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 310. China Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 311. China Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 312. China Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 313. China Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 314. China Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 315. China Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 316. China Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 317. India Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 318. India Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 319. India Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 320. India Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 321. India Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 322. India Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 323. India Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 324. India Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 325. India Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 326. Japan Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)
  • TABLE 327. Japan Pet Disease Diagnostic Reagent Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 328. Japan Pet Disease Diagnostic Reagent Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 329. Japan Pet Disease Diagnostic Reagent Market Size, by Parasitic Disease, 2017-2032 (USD Million)
  • TABLE 330. Japan Pet Disease Diagnostic Reagent Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 331. Japan Pet Disease Diagnostic Reagent Market Size, by Diagnostic Technology, 2017-2032 (USD Million)
  • TABLE 332. Japan Pet Disease Diagnostic Reagent Market Size, by Test Type, 2017-2032 (USD Million)
  • TABLE 333. Japan Pet Disease Diagnostic Reagent Market Size, by Molecular Test, 2017-2032 (USD Million)
  • TABLE 334. Japan Pet Disease Diagnostic Reagent Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 335. Australia Pet Disease Diagnostic Reagent Market Size, 2017-2032 (USD Million)

TAB